← Back to headlines
Summit Therapeutics Claims Lead Over Merck in Cancer Drug Development
Biotechnology firm Summit Therapeutics reports promising clinical data suggesting its oncology treatment outperforms Merck's competing cancer therapy.
3 Sept, 16:00 — 3 Sept, 16:00
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Board Approves Restructuring Plan to Cut 100,000 Jobs by 2030
32m ago
Trump Administration Asks Supreme Court to Lift Block on Mail Ballot Restrictions
40m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
2h ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
2h ago